PubMed:30592011 / 939-1140 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/30592011","sourcedb":"PubMed","sourceid":"30592011","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/30592011","text":"In this study, we aimed to better understand the molecular consequences of chronic LRRK2 kinase inhibition, which may be pivotal in the further development of a LRRK2 kinase inhibitor-based PD therapy.","tracks":[{"project":"PubMed_ArguminSci","denotations":[{"id":"T7","span":{"begin":0,"end":201},"obj":"DRI_Challenge"}],"attributes":[{"subj":"T7","pred":"source","obj":"PubMed_ArguminSci"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubMed_ArguminSci","color":"#ec93bb","default":true}]}]}}